MoraliSharmaMD
Endocrinology • Point Richmond, CADiabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology, Thyroid
Houston Methodist Specialty Physician Group
Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
901 Nevin Ave
Point Richmond, CA 94801Phone+1 510-307-1500- Is this information wrong?
Education & Training
University of California, San DiegoResearch fellowship, 1993 - 1994
Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1990 - 1993
Cook County Health and Hospitals SystemResidency, Internal Medicine, 1987 - 1990
Baroda Medical CollegeClass of 1983
Certifications & Licensure
CA State Medical License 1988 - 2024
TX State Medical License 1994 - 2019
IL State Medical License 1987 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- • Fulbright & Jaworski L.L.P. Faculty Excellence Award, Teaching & Evaluation Baylor College of Medicine, 2004
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- 76 citationsHyperthyroidism and the Heart.Patricia Mejia Osuna, Maja Udovcic, Morali D Sharma> ;Methodist Debakey Cardiovascular Journal. 2017 Apr 1
- 23 citationsCardiovascular Disease in Acromegaly.Morali D Sharma, Anh V Nguyen, Spandana Brown, Richard J. Robbins> ;Methodist Debakey Cardiovascular Journal. 2017 Apr 1
- 21 citationsPotential for combination of dipeptidyl peptidase‐4 inhibitors and sodium‐glucose co‐transporter‐2 inhibitors for the treatment of type 2 diabetesMorali D. Sharma> ;Diabetes, Obesity & Metabolism. 2015 Jul 1
- Join now to see all
Journal Articles
- Potential for Combination of dipeptidyl peptidase-4 Inhibitors and sodium-glucose co-transporter-2 Inhibitors for the Treatment of Type 2 diabetes.Morali Sharma, Diabetes, Obesity and Metabolism, 7/2015
Professional Memberships
- Member
- Member
Other Languages
- Hindi, Gujarati
Hospital Affiliations
Kaiser Permanente Oakland Medical CenterOakland, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
